article thumbnail

Pharma Injecting Life into Digital Health Amidst Funding Downturn

MedCity News

The earliest higher-profile digital therapeutic leaders focused on mental and behavioral health with some earning Food and Drug Administration approval for managing conditions such as attention-deficit and hyperactivity disorder, substance-use disorder, and insomnia using a prescription-level app alone or in conjunction with pharmacologic therapy.

Pharma 109
article thumbnail

Understanding a rare disease through the lens of real world and prevalence data

Clarivate

Our analysis included prescription trends for antibiotics, steroids, vitamins and ophthalmic-intraocular pressure reducing agents (prostaglandin analogs and alpha-adrenergic agonists) from 2018 to 2021. Frontiers in Pharmacology; 13:1089033; DOI: 10.3389/fphar.2022.1089033 ” Ophthalmology; V.127;